Compare RDHL & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RDHL | SGLY |
|---|---|---|
| Founded | 2009 | 2001 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 5.3M |
| IPO Year | 2012 | 2008 |
| Metric | RDHL | SGLY |
|---|---|---|
| Price | $0.95 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.0K | ★ 78.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,813,193.00 |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.91 | $0.34 |
| 52 Week High | $3.47 | $1.86 |
| Indicator | RDHL | SGLY |
|---|---|---|
| Relative Strength Index (RSI) | 38.56 | 45.10 |
| Support Level | $0.91 | $0.34 |
| Resistance Level | $1.45 | $0.67 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 36.81 | 27.87 |
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.